Iris Dirven

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Universitair Ziekenhuis Brussel(Current)

Vrije Universiteit Brussel

Iris Dirven is an author at Universitair Ziekenhuis Brussel specializing in oncology, stereotactic radiotherapy, and central nervous system radiation oncology.

ORCID

Publications per year

2023–2024

Publications

Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma

Johnny Duerinck, Louise Lescrauwaet, Iris Dirven et al. · Neuro-Oncology · 2024 · 27 citations · Full text

Medicine, Neurosurgery, Oncology +17

Low-Dose Bevacizumab for the Treatment of Focal Radiation Necrosis of the Brain (fRNB): A Single-Center Case Series

Jens Tijtgat, Evan Calliauw, Iris Dirven et al. · Cancers · 2023 · 16 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [18F]FDG PET/CT Imaging and Clinical Features

Ine Dirks, Marleen Keyaerts, Iris Dirven et al. · Cancers · 2023 · 10 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells in solid tumors

Manon Vounckx, Jens Tijtgat, Latoya Stevens et al. · Cancer Immunology Immunotherapy · 2024 · 10 citations · Full text

Medicine, Oncology, Radiation Oncology +16

1–4 of 4